Financial Ratios

UNJHA FORMULATIONS LTD.

NSE : NABSE : 531762ISIN CODE : INE576D01015Industry : Pharmaceuticals & DrugsHouse : Private
BSE19.67-1.58 (-7.44 %)
PREV CLOSE ( ) 21.25
OPEN PRICE ( ) 21.68
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 1538
TODAY'S LOW / HIGH ( )19.60 21.68
52 WK LOW / HIGH ( ) 10.5524.87
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.630.560.230.690.67
   CEPS(Rs)0.800.730.410.860.86
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)5.484.844.284.053.36
   Tax Rate(%)14.2915.7268.560.000.00
Margin Ratios
   Core EBITDA Margin(%)3.292.273.662.342.62
   EBIT Margin(%)2.953.055.034.012.76
   Pre Tax Margin(%)2.512.123.312.912.63
   PAT Margin (%)2.151.781.042.912.63
   Cash Profit Margin (%)2.732.321.863.653.38
Performance Ratios
   ROA(%)8.237.232.868.377.89
   ROE(%)12.2212.355.5518.5724.22
   ROCE(%)16.7621.1326.8025.5725.41
   Asset Turnover(x)3.834.062.752.883.00
   Sales/Fixed Asset(x)3.063.342.372.582.83
   Working Capital/Sales(x)9.6812.8612.5515.7429.31
Efficiency Ratios
   Fixed Capital/Sales(x)0.330.300.420.390.35
   Receivable days24.2121.5438.9842.8533.80
   Inventory Days30.6128.5629.9017.7925.05
   Payable days42.3849.5393.8798.23113.01
Valuation Parameters
   PER(x)19.8316.6636.788.3611.92
   PCE(x)15.6012.7920.616.659.26
   Price/Book(x)2.281.941.991.422.38
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)0.430.270.370.150.26
   EV/Core EBITDA(x)12.057.446.253.257.30
   EV/EBIT(x)14.438.757.273.859.30
   EV/CE(x)1.641.091.030.440.80
   M Cap / Sales0.430.300.380.240.31
Growth Ratio
   Net Sales Growth(%)-7.1342.28-6.10-7.181.12
   Core EBITDA Growth(%)-8.73-12.5815.4525.476.04
   EBIT Growth(%)-10.30-13.6617.8134.7713.31
   PAT Growth(%)11.88143.86-66.422.7014.35
   EPS Growth(%)11.88143.86-66.422.6914.35
Financial Stability Ratios
   Total Debt/Equity(x)0.000.000.000.000.00
   Current Ratio(x)2.421.861.491.351.18
   Quick Ratio(x)1.231.020.781.100.93
   Interest Cover(x)6.693.262.933.6521.22
   Total Debt/Mcap(x)0.000.000.000.000.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.